JP4852218B2 - Alcohol metabolism promoter composition - Google Patents
Alcohol metabolism promoter composition Download PDFInfo
- Publication number
- JP4852218B2 JP4852218B2 JP2002505020A JP2002505020A JP4852218B2 JP 4852218 B2 JP4852218 B2 JP 4852218B2 JP 2002505020 A JP2002505020 A JP 2002505020A JP 2002505020 A JP2002505020 A JP 2002505020A JP 4852218 B2 JP4852218 B2 JP 4852218B2
- Authority
- JP
- Japan
- Prior art keywords
- alcohol
- hangover
- fermentation
- citrus molasses
- alcohol metabolism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims description 97
- 239000000203 mixture Substances 0.000 title claims description 46
- 230000004060 metabolic process Effects 0.000 title claims description 30
- 238000000855 fermentation Methods 0.000 claims description 52
- 230000004151 fermentation Effects 0.000 claims description 52
- 235000013379 molasses Nutrition 0.000 claims description 52
- 235000020971 citrus fruits Nutrition 0.000 claims description 50
- 241000207199 Citrus Species 0.000 claims description 49
- 206010019133 Hangover Diseases 0.000 claims description 49
- 230000000694 effects Effects 0.000 claims description 49
- 239000000284 extract Substances 0.000 claims description 35
- 241000190633 Cordyceps Species 0.000 claims description 31
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims description 25
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 22
- 230000002265 prevention Effects 0.000 claims description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 14
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241001672694 Citrus reticulata Species 0.000 claims description 5
- 206010025482 malaise Diseases 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 48
- 239000000047 product Substances 0.000 description 39
- 239000012141 concentrate Substances 0.000 description 25
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 14
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 14
- 235000013305 food Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000035622 drinking Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000007357 dehydrogenase reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 229940048086 sodium pyrophosphate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HORQAOAYAYGIBM-UHFFFAOYSA-N 2,4-dinitrophenylhydrazine Chemical compound NNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HORQAOAYAYGIBM-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 102100026605 Aldehyde dehydrogenase, dimeric NADP-preferring Human genes 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710188314 Protein V Proteins 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
- C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Description
技術分野
本発明は、アルコール代謝促進剤組成物及び悪酔い又は二日酔い予防改善剤組成物に関する。
背景技術
経口的に摂取(飲酒)したアルコールの大部分は、上部消化管で吸収され、肝臓で代謝されるが、肝臓にはアルコールの酸化を規定する制御機構が存在していない。そのためアルコールを過剰に摂取すると、肝臓でのアルコール代謝が選択的に亢進し、その結果として肝臓内の代謝系に大きな変動を伴うことになる。摂取したアルコールの大部分は、肝細胞のサイトゾールに存在するアルコール脱水素酵素系を介してアセトアルデヒドとなり、アセトアルデヒドはさらにアルデヒド脱水素酵素による脱水素反応を受けて酢酸に変換される。アルコール摂取量が多すぎたり、体調が悪くてアルコールの代謝が遅れたりすると、アセトアルデヒドが処理しきれなくなり、血中のアセトアルデヒド濃度が高くなる。アセトアルデヒドは強い毒性があり、胃腸のムカツキ、吐き気、頭痛、二日酔い等の不快症状の原因となる。よって、アルコール摂取後に生じるアセトアルデヒドをいかに血中から速やかに消失させるかが悪酔いや二日酔いの予防に重要である。そこで、アルデヒド脱水素酵素の活性を高める作用を有する経口物質、すなわち、アセトアルデヒドの代謝を促進する経口物質は、上記の悪酔いや二日酔いの予防や改善に効果があると考えられる。このような経口物質として、例えば、とうもろこし蛋白質を酵素分解して得られる分子量200〜4,000のペプチドを有効成分とするアルコール代謝促進剤(特開平7−285881)、豚肉をプロテアーゼで処理して得られる豚肉加工品を含有するアルコール代謝促進作用物(特開平11−276116)、あるいはイソフラボノイドを有効成分とする二日酔い防止食品(特開平2000−7694)、などが提供されている。
本発明は、アルデヒド脱水素酵素活性を促進するがアルコール脱水素酵素活性には実質的に影響しないユニークなアルコール代謝促進剤組成物を提供することを課題とする。また、該組成物を有効成分として含有する悪酔い又は二日酔い予防改善剤組成物を提供することを課題とする。
発明の開示
本発明者らは、ラットに対し、柑橘糖蜜のアルコール発酵産物の濃縮液に冬虫夏草抽出物を配合した組成物を、エタノール経口投与前に予め経口投与しておくと、対照に対して、血中エタノール濃度には有意な変化は認められなかったが、血中アセトアルデヒド濃度は有意に低下することを見出した。この結果がどのような作用機序に起因しているかを、柑橘糖蜜のアルコール発酵産物の濃縮液を添加した酵素反応系で調べたところ、該濃縮物は、アルデヒド脱水素酵素の活性を増強する作用があり、一方、アルコール脱水素酵素の活性には影響を及ぼさないことから、この濃縮物が悪酔い又は二日酔いの予防改善に有用であることを見出した。
すなわち、本発明は、柑橘糖蜜をサッカロミセス属酵母を用いてアルコール発酵させて得られる発酵産物を含有するアルコール代謝促進剤組成物及び悪酔い又は二日酔い予防改善用組成物を提供するものである。
また、本発明は上記発酵産物及び冬虫夏草抽出物を含有するアルコール代謝促進剤組成物及び悪酔い又は二日酔い予防改善剤組成物を提供するものである。
さらに本発明は上記発酵産物の、アルコール代謝促進剤組成物及び悪酔い又は二日酔い予防改善用組成物製造のための使用を提供するものである。
さらに、本発明は上記発酵産物及び冬虫夏草抽出物の、アルコール代謝促進剤組成物及び悪酔い又は二日酔い予防改善用組成物製造のための使用を提供するものである。
さらに、本発明は上記組成物の有効量を投与することを特徴とするアルコール代謝促進方法、及び悪酔い又は二日酔い予防改善方法を提供するものである。
さらにまた本発明は上記組成物及び冬虫夏草抽出物の有効量を投与することを特徴とするアルコール代謝促進方法、及び悪酔い又は二日酔い予防改善方法を提供するものである。
発明を実施するための最良の形態
柑橘糖蜜の製造法は公知である(例えば特開平10−276578)。温州みかんなどの柑橘類を搾汁して果汁を製造するときに発生する搾汁粕は、約10〜15%の可溶性固形物を含んでおり含水量が多い。この搾汁粕(外果皮、果皮、及びじょうのう膜を含む)に、脱水を容易にするために消石灰を加えライミングを行った後圧搾して得た搾汁を、Brix50〜70%に濃縮した粘ちょう状の液は、「柑橘糖蜜」とよばれる。また、柑橘糖蜜からパルプなどの不溶性成分を除去したものは、「脱パルプ柑橘糖蜜」とよばれ、これも本発明に使用できる。
柑橘類としては、温州みかん以外に、例えば、夏みかん、伊予柑、グレープフルーツ、マンダリンオレンジ、レモンなどの柑橘、あるいはユズ、カボス、スダチ、ダイダイ、サンポウカンなどが含まれる。
本発明により、アルコール摂取前に温州みかん等の柑橘糖蜜の発酵産物を経口摂取すると、血中アセトアルデヒドが低下することが明らかとなった。そして、この現象は、該発酵産物がアセトアルデヒド代謝酵素活性を高める作用に基づくものであることが明らかとなった。すなわち、柑橘糖蜜の発酵産物からなる組成物は、悪酔いや二日酔いに有効であることが明らかにされた。
柑橘糖蜜を酵母を用いてアルコール発酵することにより、本発明のアルコール代謝促進作用を有する組成物が得られる。柑橘糖蜜のアルコール発酵は、当業者公知の、廃糖蜜を原料とするアルコール発酵法に準じて行うことができる。
柑橘糖蜜は不溶性のパルプ含量が高いため、食品素材として使用するには、遠心分離できるように希釈して遠心分離し、パルプを除去することが好ましい。この脱パルプ柑橘糖蜜は、酵母が資化可能な糖質を多量に含んでいる。そこで、有効成分の濃縮を目的に、脱パルプ柑橘糖蜜を酵母でアルコール発酵処理し、該柑橘糖蜜中の資化糖を、エタノール及び炭酸ガスに変換して有効成分の比率を高める処理をする。
脱パルプ柑橘糖蜜を水で希釈して、糖度を10〜20%程度に調整する。栄養源として硫酸アンモニウム、アンモニア水、尿素などの窒素源、さらに必要あれば、過燐酸石灰、リン酸アンモニウムなどのリン酸塩を加える。pHをほぼ5に調整して加熱殺菌(60℃で30分、あるいは85℃で15分)する。冷却(30〜35℃)した後、酵母を加えアルコール発酵させる。発酵温度は、27±7℃である。酵母としては、市販のパン酵母Saccharomyces cerevisiaeが最もよいが、その他の酵母、例えば、S.formosensis、S.carlsbergensis、S.ellipsoideus、S.rouxii、あるいはS.sakeなども用いてみてもよい。
発酵が進むにつれて、Brix糖度は低下する。発酵終了は、30分経過時のBrix糖度変化が0.1%以下を目安とする。発酵産物は、粘ちょう度が低下しており、さらに有効成分を濃縮することが可能である。濃縮液は、菌体分離、清澄化、殺菌、濃縮、再殺菌の工程を経て、最終的に本発明のアルコール代謝促進組成物が得られる。この組成物は、さらに乾燥粉末としてもよい。
冬虫夏草は、子嚢菌類(Ascomycetes)、麦角菌目(Clavicipitales)、麦角菌科(Hypocreaceae)、冬虫夏草属(Cordyceps)に属し、完全世代と不完全世代とを有する微生物である。冬虫夏草は、その子実体が、不老長寿の妙薬として、あるいは滋養強壮の妙薬として、古来より珍重されてきた。このようにして従来より漢方薬として珍重されてきた冬虫夏草は、通常、子実体を粉末化し、これを服用するものである。
本発明で用いる冬虫夏草は、上記子実体も用いることができると考えられるが、Cordyceps sinensis(Berk.)SaccやCordyceps militarisの菌糸体は大量培養が可能であり、これらの培養菌糸体から熱水で有効成分を抽出して得られる抽出物(例えばWO96/00580及び特開平8−12588号)を用いるのがよい。該抽出物を柑橘糖蜜の発酵産物に添加すると、アルデヒド脱水素酵素活性をさらに高めることが明らかにされた。冬虫夏草菌糸体の培養及び抽出操作は、公知方法(例えばWO96/00580及び特開平8−12588号)である。
すなわち、Cordyceps sinensisの培養菌子体を、麦芽エキス、酵母エキス、ペプトン、バレイショ煮出汁、ブドウ糖、ビタミン類、アミノ酸、核酸、蛋白質、及び必要に応じ、昆虫等寄主の成分などを加えた培地に接種し、液体又は固体培養を行う。大量培養の場合は、通気攪拌型発酵槽(100〜300rpm)による液体培養を用いる。培養は、pH4〜7、培養温度20〜30℃、3〜10日間行う。培養終了後、培養菌子体を熱水(85〜100℃)抽出する。あるいは水又は水に可溶性の少量の酸、塩基又は有機溶媒を含む水系溶媒にて抽出してもよい。遠心分離、あるいは濾過などにより残さを取り除く。得られた冬虫夏草の熱水抽出物は、そのまま本発明に使用してもよいが、常法により濃縮、あるいは凍結乾燥粉末として使用してもよい。
柑橘糖蜜の発酵産物を、アルコール摂取前に摂取すると、血中アセトアルデヒドが低下する。また、発酵産物と冬虫夏草の抽出物を併せて摂取すると血中アセトアルデヒドがさらに低下する。すなわち、柑橘糖蜜の発酵産物、あるいは該発酵産物と冬虫夏草の抽出物との混合組成物を摂取すると、悪酔いや二日酔い予防改善効果が得られる。この予防効果は、上記したように、柑橘糖蜜の発酵産物がアルデヒド脱水素酵素の活性を高める作用に基づく。冬虫夏草の抽出物にはアルデヒド脱水素酵素の活性を高める作用は認められない。冬虫夏草抽出物が該酵素活性を高める理由は明らかではないが、冬虫夏草抽出物には、肝血流量の増加作用(Food Style 21,vol.2,No.5,1998)、及び肝臓でのATP産生量を高める作用(Jpn.J.PHarmacol.,70:85−88,1996)が知られている。冬虫夏草抽出物による肝血流量の増加は、該発酵産物の肝臓への流入を促進し、肝細胞内のアルデヒド脱水素酵素活性を高めると考えられる。また、アルデヒド脱水素酵素が作用するには、補酵素のNADが必要であり、NADはニコチン酸とATPより合成されることから、ATP量の増大は、結果的にNADの合成を促進し、アルデヒド脱水素酵素の活性を高めると考えられる。
柑橘糖蜜の発酵産物中のアルデヒド脱水素酵素活性を高める成分を分析した結果、いくつかの成分が含まれていることが判明したが、これら成分の有効濃度と発酵産物中の含有量を考慮すると、発酵産物の該作用を、これら各成分の有するそれぞれの作用で説明することはできない。また、これらの成分を発酵産物の含有量割合に混合した組成物も、発酵産物の該作用を説明できない。その結果、発酵産物のアルデヒド脱水素酵素の活性を高める作用は、発酵産物含有成分の複合的な作用に基づくものであると考えられる。
柑橘糖蜜の発酵産物、あるいは該発酵産物と冬虫夏草抽出物との混合組成物の摂取時期は、アルコール摂取前が望ましいと考えられるが、その作用機作から、アルコール摂取時、あるいは摂取後でも、悪酔いや二日酔いの軽減に効果が期待できる。該組成物を予め摂取しておくことにより、アルデヒド脱水素酵素の活性が高まり、飲酒により生じる有害な血中アセトアルデヒドが低下するが、一方、アルコール脱水素酵素の活性に対しては実質的な影響はなく、飲酒の楽しさである“ほろ酔い気分”をこわさずに、悪酔いや二日酔いを予防する、というユニークな作用が得られる。
柑橘糖蜜の発酵産物は、風味が良好でそのまま経口摂取可能であるので、悪酔いや二日酔い予防のために、該発酵産物を、その有効量を含む剤型に製剤化して用いることもできる。このような製剤技術は当業者に周知である。有効量は、アルコールを同量飲んでも、その吸収代謝速度は、体重、体質などの違いにより非常に個人差が大きく、明確には算定することはできないが、ラットの試験結果から、約1〜10g(乾燥固形分換算)/成人と推定される。毒性に関しては、柑橘糖蜜は食品素材として長年用いられてきており、長年の食経験からその安全性は保証されている。
また、本発明の発酵産物、あるいは該発酵産物と冬虫夏草抽出物を、悪酔いや二日酔い予防のために、飲食時にその有効量を直接飲食品に添加して用いてもよい。また、有効量を含む飲食品に加工してもよい。例えば、ドリンク剤として、糖質10%、酸味量0.1%、果汁2〜3%、フレーバー0.1%、に柑橘糖蜜の発酵産物5.3%、及び冬虫夏草抽出エキス1.7%を加えて、pHを3.5〜4.0に調整した後、65℃で10分間加熱殺菌し、次いで冷却・瓶詰めする。さらに、該ドリンク剤に脂肪酸の代謝改善効果を有するγ−リノレン酸及び/又はアラキドン酸カスケード内の脂肪酸を添加して、肝臓の脂質代謝機能の増進を補完することが考えられる。同様に他の機能性ドリンク剤、特定保健用食品などに配合してもよい。
飲食品としては、上記の他、健康食品、栄養補助食品、及び治療用食品を含んでもよい。さらに、飲酒後の口臭を軽減するために、口臭予防作用を有する食品(例えば緑茶ポリフェノール)を併用してもよい。
柑橘糖蜜の発酵産物に冬虫夏草抽出物を添加(配合)する場合は、その配合割合(重量)は、発酵産物:冬虫夏草エキス=20〜30:1〜3程度(固形分換算)と推定されるが、最適配合割合は、当業者であれば、さらなる実験により容易に決定することができるので、このようにして決定された配合割合も本発明に包含される。得られた混合組成物は均一であることが好ましい。
本発明の発酵産物と冬虫夏草抽出物との混合組成物に加うるに、さらにアミノ酸を含有させてもよい。アミノ酸を含有させることにより、アルコールの胃や腸での吸収の阻害作用を補完させたり、NAD系に関与してアルコール代謝を促進させることができる(Biol.PHarm.Bull.,18(12):1653−1656,1995;Alcohol and Aldehyde metabolizing system−IV:p.109,1980)。アミノ酸としては、例えば、グリシン、L−アスパラギン酸、L−システィン、L−セリン、L−アラニン、L−メチオニンなどが挙げられる。
実施例
以下、実施例及び試験例により本発明を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。
[実施例1] 柑橘糖蜜の発酵産物の濃縮
温州みかん1000kgをインライン搾汁機で搾汁して、果汁500kgと搾汁粕500kgを得た。この搾汁残さ500kgに消石灰を加え(約0.3%)、ライミングした後圧搾して搾汁液250kgと搾汁粕250kgを得た。この搾汁液をBrix糖度40〜50%まで循環濃縮して柑橘糖蜜50kg(Brix45%、pH8〜9)を得た。柑橘糖蜜は、使用時まで冷凍保管した。
この柑橘糖蜜を解凍し、クエン酸でpH調整(pH6.0±0.5、10±5℃)後、熱水で希釈(50℃以上、Brix10±5%)し、遠心分離(5100G)して不溶性成分(パルプ質)を除去した。パルプ質を除去した糖蜜はプレート殺菌(88℃・15秒保持)した後、プレート式濃縮機で濃縮し、10℃以下に冷却した。Brix調整(Brix50±1%、パルプ20%以下、pH6.0±1)を脱パルプ糖蜜37kg得た。
脱パルプ糖蜜を温水に溶解した。栄養源(窒素源)として硫酸アンモニウム、消泡剤としてアワブレークG−109、pH調整剤としてクエン酸を、それぞれ5倍量の水に溶解して上記脱パルプ糖蜜仕込み液に添加した。仕込み液はBrix糖度13±1%、pH5±0.2となるように調整した。仕込み液中の脱パルプ糖蜜量は27%(重量)であった。仕込み液は、バッチ殺菌(85℃、15分)後、34±4℃まで冷却した。仕込み液にパン酵母(0.5%)を接種して発酵させた。酵母は、脱パルプ柑橘糖蜜中に含まれる糖を資化して炭酸ガスを発生し、発酵が進むにつれて、Brix糖度とpHは低下する。発酵時間はおよそ5〜6時間である。発酵終了時点は、30分経過時のBrix糖度変化が0.1%以下の時を目安とする。発酵終了後、加熱(85℃、15分)して酵母を失活させた後、発酵液に含まれるスラッジ(酵母菌体、パルプ)を全自動圧搾機及びフィルタープレスで除去した。次いで、その上清をプレート殺菌(134℃、3秒)した。殺菌時に生じる不溶性成分をキュノーフィルターで除去後、減圧濃縮した。この濃縮物は再殺菌(8℃、30秒)後冷却して、本発明のアルコール代謝促進組成物(Brix45±2%)10kgを得た。
[実施例2] 冬虫夏草抽出物の製造
M20Y2培地150mLを500mL容三角フラスコに採りオートクレーブ滅菌した。この培地に、Cordyceps sinensis MF−20008(FERM BP−5149)の凍結保存菌糸体1mLを接種し、25℃、180rpmで5日間振とう培養した。これを種菌として、以下のように150L大量培養を行った。
D培地(1L中の組成:蔗糖 40.0g.K2HPO4 4.0g、アスパラギン0.5g、(NH4)2HPO4 2.0g、MgSO4・7H2O 2.0g、CaCO3 0.25g、CaCl2 0.1g、酵母エキスB−2 4.0g、pH5.6)150Lを、150Lファーメンターに無菌濾過処理後投入し、上記の種培養液150mLを接種し、25℃、pH5.5、DO 50%に制御し、157rpmで攪拌しながら、3日間培養した。この間、発生する泡は、シリコン消泡剤投入により処理した。培養により得られた150L培養液を、クラリファイヤーにより菌体分離処理を行い、菌体の水懸濁液を得た。これを90から95℃の間で、2時間保持することにより加熱抽出処理を行った後、クラリファイヤーによる清澄化を行い、上清液を得た。これを0.45μm、及び0.22μm無菌フィルターを用い濾過し、淡黄色の熱水抽出液80L(固形物乾燥重量800g)を得た。
[実施例3] 二日酔い予防ドリンク剤の製造
以下の原料配合割合(単位:kg)で二日酔い予防ドリンク剤を製造した。
柑橘糖蜜発酵産物の濃縮液(製造例1で得られたもの): 52.5
冬虫夏草抽出物(製造例2で得られたもの) : 16.7
糖 : 40
果汁 :100
アスコルビン酸 : 1
クエン酸 : 3
香料 : 4
水 :782.8
全量 1000
上記を溶解し95℃で20分間殺菌した後、ビンに無菌的に120mLづつ充填し二日酔い予防ドリンク剤を得た。
[試験例1] アルコール代謝促進作用(in vivo)
6週齢の雄性ウイスター系ラット(体重160〜170g)を用いた。試験物質として実施例1で得た柑橘糖蜜の発酵産物の濃縮物と実施例2で得た冬虫夏草抽出物を用いた。試験群として、(1)濃縮物2,000mg/kg投与群、(2)冬虫夏草抽出物200mg/kg+濃縮物2,000mg/kg投与群、及び(3)陰性対照群として蒸留水投与群(10mL/kg)の3群(1群6匹)を設定した。24時間絶食後、蒸留水に溶解した濃縮物溶液、あるいは蒸留水を10mL/kg体重となるように経口投与した。その1時間後に、20%(W/V)エタノールを10mL/kg体重となるように経口投与した。エタノール投与1時間後にエーテル麻酔下で大腿静脈より採血した。さらにエタノール投与3時間後にエーテル麻酔下で後大静脈より採血した。血中エタノール濃度は、Fキットエタノール(ロシュ・ダイアグノスティックス社製)を用いて測定した。結果を図1に示す。一方、血中アセトアルデヒド濃度は、Cario Di Padovaらの方法(ALCHOLISM:CLINICAL AND EXPERIMENTAL RESERCH,vol.10,No.1,p86〜89,1986)に準じて測定した。すなわち、アセトアルデヒドをDNP(2,4ジニトロフェニルヒドラジン)試薬で誘導体生成後にHPLC(高速液体クロマトグラフィー)を用いて測定した。結果を図2に示す。
エタノール経口投与1時間後、及び3時間後の血中アルコール濃度は、図1から明らかなように、濃縮物2000mg/kg投与群、冬虫夏草抽出物200mg/kg+濃縮物2000mg/kg投与群、陰性対照群である蒸留水投与群(10mL/kg)の間に、統計的な有意差が認められなかった。
一方、エタノール経口投与後の血中アセトアルデヒド濃度については、図2から明らかなように、1時間後においては、濃縮物投与群と対照群との間に統計的有意差はみられないが、濃縮物投与により、血中アセトアルデヒド濃度が低下傾向にあり、これに冬虫夏草抽出物が加わると、血中アセトアルデヒド濃度が有意に低下することが認められる。3時間後においては、濃縮物投与群と対照群との間に差は認められないが、濃縮物+冬虫夏草抽出物投与群では、なお血中アセトアルデヒド濃度の低下傾向が認められた。
以上の結果から、アルコール経口摂取前に本発明の柑橘糖蜜の発酵産物の濃縮物を経口摂取することにより、血中のエタノール濃度は低下しないが、アセトアルデヒド濃度は低下傾向にあり、該濃縮物とともに冬虫夏草の抽出物を経口摂取すると、アセトアルデヒド濃度の低下が増強され、その低下時間も延長されることが明らかとなった。
[試験例2] 柑橘糖蜜の発酵産物の濃縮液がアルコール代謝酵素活性に及ぼす効果
上記動物実験で得られた二日酔い予防効果がどのような作用機序で機能しているかを、in vitroでの酵素反応系(生化学実験講座,タンパク質V,日本生化学会編,p269−285)を構築して調べた。
アルコール脱水素酵素、アルデヒド脱水素酵素の活性測定は、これらの酵素が反応する際の補酵素、β−NADがNADHへと変換することを利用した。β−NAD、NADHは紫外部の吸収極大波長に違いが見られ、β−NADではほとんど見られない340nm付近にNADHの吸収が見られる。すなわち、340nmの紫外部吸収を測定することは、アルコール脱水素酵素、アルデヒド脱水素酵素の酸化還元反応の活性の指標として利用できる。
・アルコール脱水素酵素反応液
ピロリン酸ナトリウム(リン酸でpH10.0調製)32mM
基質:エタノール33mM
β−NAD2.4mM
酵素溶液:アルコール脱水素酵素(SIGMA,EC1.1.1.1,ウマ肝臓由来,5mUnits/mL)
精製水
・アルデヒド脱水素酵素反応液
ピロリン酸ナトリウム(リン酸でpH8.0に調製)32mM
基質:アセトアルデヒド4mM
β−NAD4mM
ピラゾール0.1mM
EDTA1mM
酵素溶液:アルデヒド脱水素酵素(SIGMA,EC1.2.1.5,パン酵母由来,0.5Units/mL)
精製水
酵素反応液は全量が0.2mLとなるように調製した。基質は最後に添加し、基質添加後速やかに340nmの吸光値を測定した。その後、37℃で10分反応させた。反応後の340nmの吸光値を測定し、吸光値の増加量を算出し、酵素活性の上昇を検討した。アルコール脱水素酵素活性を図3に、アルデヒド脱水素酵素活性を図4にそれぞれ示す。アルコール脱水素酵素反応系に発酵濃縮物を様々な濃度で添加しても、無添加の場合と酵素活性に変化は認められない(図3)。一方アルデヒド脱水素酵素反応系に、発酵濃縮物を様々な濃度で添加すると、アルデヒド脱水素酵素活性が発酵濃縮物の濃度依存的に上昇した。これより、発酵濃縮物は、アルコール脱水素酵素活性には影響せず、アルデヒド脱水素酵素の活性を上昇させる効果があることが明らかとなった。これらの実験結果から、柑橘糖蜜の発酵濃縮物は、アルデヒド脱水素酵素の活性を上昇させることにより、アセトアルデヒドの分解を促進し、結果血中アセトアルデヒド濃度を減衰させることが明らかとなった。
産業上の利用可能性
本発明の柑橘糖蜜の発酵濃縮物を経口摂取すると、アルデヒド脱水素酵素活性が増強し、また、冬虫夏草抽出物と併用すると、上記酵素活性がさらに増強するとともに、その持続時間が延長するので、これらを飲酒前に経口摂取すると、二日酔いや悪酔いなどの不快な症状を抑制あるいは軽減させることができる。さらに、アルコール脱水素酵素活性には影響を及ぼさないので、酩酊感(ほろ酔い気分)は妨げないことが期待される。
また、本発明のアルコール代謝促進組成物は、継続的に摂取することによって、アルコール代謝能力を高め、アルコール依存症や、肝臓などの臓器障害の予防にも役立つと考えられる。
【図面の簡単な説明】
図1は、ラットに対する、柑橘糖蜜の発酵産物の濃縮物2,000mg/kg経口投与、及び冬虫夏草抽出物200mg/kg+濃縮物2000mg/kg経口投与が、その後のエタノール経口投与による血中アルコール濃度におよぼす影響を示すグラフである。
図2は、同じく、血中アセトアルデヒド濃度におよぼす影響を示すグラフである。*:p<0.05(Student’s test)
図3は、in vitroにおける柑橘糖蜜の発酵産物の濃縮物のアルコール脱水素酵素活性に及ぼす効果を示す図である。
図4は、同じくアルデヒド脱水素酵素活性に及ぼす効果を示す図である。TECHNICAL FIELD The present invention relates to an alcohol metabolism promoter composition and a hangover or hangover prevention improving composition.
BACKGROUND ART Almost of alcohol taken orally taken (drinked) is absorbed in the upper gastrointestinal tract and metabolized in the liver, but there is no control mechanism in the liver that regulates the oxidation of alcohol. Therefore, when alcohol is excessively consumed, alcohol metabolism in the liver is selectively enhanced, and as a result, the metabolic system in the liver is greatly changed. Most of the ingested alcohol is converted into acetaldehyde through the alcohol dehydrogenase system present in the cytosol of hepatocytes, and the acetaldehyde is further converted to acetic acid through a dehydrogenation reaction by the aldehyde dehydrogenase. If the amount of alcohol intake is too high, or if the physical condition is bad and the metabolism of alcohol is delayed, acetaldehyde cannot be completely processed, and the concentration of acetaldehyde in the blood increases. Acetaldehyde is highly toxic and causes discomfort such as gastrointestinal irritations, nausea, headache, and hangover. Therefore, how to quickly eliminate acetaldehyde generated after alcohol intake from the blood is important for prevention of hangover and hangover. Therefore, it is considered that an oral substance having an action of increasing the activity of aldehyde dehydrogenase, that is, an oral substance that promotes the metabolism of acetaldehyde is effective in preventing and improving the above-mentioned sickness and hangover. As such an oral substance, for example, an alcohol metabolism promoter (JP-A-7-285881) containing a peptide having a molecular weight of 200 to 4,000 obtained by enzymatic degradation of corn protein as an active ingredient, and pork treated with protease Alcohol metabolism promoting agents containing processed pork products obtained (JP-A-11-276116), hangover foods containing isoflavonoids as active ingredients (JP-A 2000-7694), and the like are provided.
An object of the present invention is to provide a unique alcohol metabolism promoter composition that promotes aldehyde dehydrogenase activity but does not substantially affect alcohol dehydrogenase activity. It is another object of the present invention to provide an agent for preventing or improving hangover or hangover containing the composition as an active ingredient.
DISCLOSURE OF THE INVENTION The present inventors have previously orally administered a composition containing a Cordyceps extract to a rat citrus molasses alcohol fermentation product concentrate prior to oral administration of ethanol. Although no significant change was observed in the blood ethanol concentration, it was found that the blood acetaldehyde concentration significantly decreased. When the enzyme reaction system to which the concentrated liquid of the alcoholic fermentation product of citrus molasses was added was examined to determine the action mechanism of this result, the concentrate enhanced the activity of aldehyde dehydrogenase. It has an effect, but does not affect the activity of alcohol dehydrogenase. Therefore, it has been found that this concentrate is useful for the prevention and improvement of hangover or hangover.
That is, the present invention provides an alcohol metabolism promoter composition containing a fermented product obtained by subjecting citrus molasses to alcohol fermentation using Saccharomyces yeasts, and a composition for preventing or improving hangover or hangover.
The present invention also provides an alcohol metabolism promoter composition and a hangover or hangover prevention / improving agent composition containing the fermentation product and Cordyceps extract.
Furthermore, the present invention provides use of the above fermentation product for producing an alcohol metabolism promoter composition and a composition for improving the prevention of hangover or hangover.
Furthermore, the present invention provides the use of the above fermentation product and Cordyceps extract for the production of an alcohol metabolism promoter composition and a composition for improving the prevention of hangover or hangover.
Furthermore, the present invention provides a method for promoting alcohol metabolism, and a method for preventing and improving hangover or hangover characterized by administering an effective amount of the above composition.
Furthermore, the present invention provides a method for promoting alcohol metabolism and a method for preventing and improving hangover or hangover characterized by administering an effective amount of the above composition and Cordyceps extract.
BEST MODE FOR CARRYING OUT THE INVENTION A process for producing citrus molasses is known (for example, JP-A-10-276578). Juice lees generated when juice is produced by squeezing citrus fruits such as Wenzhou mandarin orange contains about 10-15% soluble solids and has a high water content. The juice obtained by squeezing after adding slaked lime to facilitate dehydration to this squeezed rice cake (including the outer skin, pericarp, and gills) is concentrated to Brix 50 to 70%. The viscous liquid is called “citrus molasses”. Moreover, what removed insoluble components, such as a pulp, from citrus molasses is called "depulped citrus molasses", and this can also be used for this invention.
Examples of citrus include citrus such as summer orange, Iyokan, grapefruit, mandarin orange, and lemon, or yuzu, kabosu, sudachi, daidai, sampoukan and the like in addition to Wenzhou oranges.
According to the present invention, it has been clarified that when a fermented product of citrus molasses such as Unshu mandarin orange is orally ingested before alcohol intake, blood acetaldehyde is lowered. And this phenomenon became clear that this fermentation product was based on the effect | action which raises acetaldehyde metabolic enzyme activity. That is, it has been clarified that a composition comprising a fermentation product of citrus molasses is effective for hangover and hangover.
By subjecting citrus molasses to alcohol fermentation using yeast, the composition having the effect of promoting alcohol metabolism of the present invention can be obtained. Alcohol fermentation of citrus molasses can be performed according to an alcohol fermentation method using waste molasses as a raw material, which is known to those skilled in the art.
Since citrus molasses has a high content of insoluble pulp, it is preferable to remove the pulp by diluting and centrifuging so that it can be centrifuged for use as a food material. This depulped citrus molasses contains a large amount of sugar that can be assimilated by yeast. Therefore, for the purpose of concentrating the active ingredient, the depulped citrus molasses is subjected to alcoholic fermentation with yeast, and the assimilated sugar in the citrus molasses is converted into ethanol and carbon dioxide to increase the ratio of the active ingredients.
The depulped citrus molasses is diluted with water to adjust the sugar content to about 10 to 20%. Nitrogen sources such as ammonium sulfate, aqueous ammonia and urea are added as nutrient sources, and phosphates such as lime perphosphate and ammonium phosphate are added if necessary. Adjust the pH to approximately 5 and heat sterilize (60 ° C. for 30 minutes or 85 ° C. for 15 minutes). After cooling (30 to 35 ° C.), yeast is added to cause alcohol fermentation. The fermentation temperature is 27 ± 7 ° C. As the yeast, commercially available baker's yeast Saccharomyces cerevisiae is the best, but other yeasts such as S. formationsensis , S. carlsbergensis , S. ellipsisideus , S. rouxii , or S. You may also use sake .
As fermentation proceeds, the Brix sugar content decreases. For the end of fermentation, the Brix sugar content change after 30 minutes is set to 0.1% or less. The fermented product has a reduced consistency and can further concentrate active ingredients. The concentrated liquid is finally subjected to the steps of cell separation, clarification, sterilization, concentration, and re-sterilization to obtain the alcohol metabolism promoting composition of the present invention. This composition may further be a dry powder.
Cordyceps belongs to Ascomycetes , Clavicipitales , Hypocreae , and Cordyceps , and is a microorganism having a complete generation and an incomplete generation. Cordyceps has been prized since ancient times for its fruiting body as a potion for immortality and longevity or as a nourishing potion. As described above, cordyceps, which has been prized as a traditional Chinese medicine, is usually obtained by powdering fruit bodies and taking them.
Cordyceps sinensis (Berk.) Sacc and Cordyceps militaryis mycelium can be cultivated in large quantities, and the mycelia of Cordyceps sinensis (Berk.) Sac can be used in hot water. It is preferable to use an extract obtained by extracting an active ingredient (for example, WO96 / 00580 and JP-A-8-12588). It has been shown that addition of the extract to the fermentation product of citrus molasses further increases aldehyde dehydrogenase activity. The cultivation and extraction of Cordyceps mycelium is a known method (for example, WO96 / 00580 and JP-A-8-12588).
That is, the cultured mycelia of Cordyceps sinensis are inoculated into a medium containing malt extract, yeast extract, peptone, potato boiled juice, glucose, vitamins, amino acids, nucleic acids, proteins, and if necessary, host ingredients such as insects. And liquid or solid culture. In the case of mass culture, liquid culture using an aeration and stirring fermenter (100 to 300 rpm) is used. Culture is performed at pH 4-7, culture temperature 20-30 ° C., 3-10 days. After completion of the culture, the cultured mycelia are extracted with hot water (85 to 100 ° C.). Alternatively, it may be extracted with water or an aqueous solvent containing a small amount of acid, base or organic solvent soluble in water. Remove the residue by centrifugation or filtration. The obtained hot water extract of Cordyceps sinensis can be used in the present invention as it is, but it may be concentrated by a conventional method or used as a freeze-dried powder.
If the fermented citrus molasses is ingested before ingesting alcohol, blood acetaldehyde will decrease. In addition, intake of fermented products and Cordyceps extract will further reduce blood acetaldehyde. That is, when a citrus molasses fermented product or a mixed composition of the fermented product and Cordyceps sinensis extract is ingested, the effects of preventing and improving hangover and hangover are obtained. As described above, this preventive effect is based on the effect that the fermentation product of citrus molasses enhances the activity of aldehyde dehydrogenase. The extract of Cordyceps sinensis does not increase the activity of aldehyde dehydrogenase. The reason why Cordyceps extract increases the enzyme activity is not clear, but Cordyceps extract has an effect of increasing hepatic blood flow (Food Style 21, vol. 2, No. 5, 1998), and ATP production in the liver. The effect of increasing the amount (Jpn. J. Pharmacol., 70: 85-88, 1996) is known. It is considered that the increase in hepatic blood flow by Cordyceps extract promotes the inflow of the fermentation product into the liver and enhances aldehyde dehydrogenase activity in hepatocytes. In addition, in order for aldehyde dehydrogenase to act, the coenzyme NAD is required, and since NAD is synthesized from nicotinic acid and ATP, an increase in the amount of ATP eventually promotes the synthesis of NAD, It is thought to increase the activity of aldehyde dehydrogenase.
As a result of analyzing components that enhance aldehyde dehydrogenase activity in the fermentation product of citrus molasses, it was found that some components were included, but considering the effective concentration of these components and the content in the fermentation product The action of the fermentation product cannot be explained by the action of each of these components. In addition, a composition in which these components are mixed in the content ratio of the fermentation product cannot explain the action of the fermentation product. As a result, it is considered that the action of increasing the activity of the aldehyde dehydrogenase of the fermentation product is based on the combined action of the fermentation product-containing components.
It is considered that the intake time of the fermented citrus molasses product or the mixed composition of the fermented product and Cordyceps sinensis extract is desirable before ingesting alcohol. And can be expected to reduce hangovers. By ingesting the composition in advance, the activity of aldehyde dehydrogenase is increased, and harmful blood acetaldehyde caused by drinking is reduced. On the other hand, there is a substantial effect on the activity of alcohol dehydrogenase. The unique effect is to prevent hangover and hangover without disturbing the “feeling of tipsy” that is the pleasure of drinking.
Since the fermented citrus molasses has a good flavor and can be taken orally as it is, the fermented product can be formulated into a dosage form containing an effective amount thereof for prevention of hangover and hangover. Such formulation techniques are well known to those skilled in the art. The effective amount of absorption even if the same amount of alcohol is consumed, the absorption metabolic rate is very large due to individual differences due to differences in body weight, constitution, etc., and cannot be calculated clearly. Estimated to be 10 g (in terms of dry solids) / adult. In terms of toxicity, citrus molasses has been used as a food material for many years, and its safety is guaranteed from years of eating experience.
In addition, the fermented product of the present invention, or the fermented product and Cordyceps extract may be used by adding an effective amount thereof directly to the food or drink during eating or drinking in order to prevent hangover or hangover. Moreover, you may process into the food / beverage products containing an effective amount. For example, as a drink,
In addition to the above, the food and drink may include health foods, nutritional supplements, and therapeutic foods. Furthermore, in order to reduce bad breath after drinking, a food having a bad breath prevention action (for example, green tea polyphenol) may be used in combination.
When the Cordyceps extract is added (mixed) to the fermented citrus molasses, the blending ratio (weight) is estimated to be about fermentation product: Cordyceps extract = 20-30: 1-3 (solid content conversion). Since the optimum blending ratio can be easily determined by a person skilled in the art through further experiments, the blending ratio thus determined is also included in the present invention. The obtained mixed composition is preferably uniform.
In addition to the mixed composition of the fermented product of the present invention and Cordyceps extract, an amino acid may be further contained. By containing an amino acid, the inhibitory action of absorption of alcohol in the stomach and intestines can be complemented, or alcohol metabolism can be promoted by participating in the NAD system (Biol. PHarm. Bull., 18 (12): 1653-1656, 1995; Alcohol and Aldehyde metabolizing system-IV: p. 109, 1980). Examples of amino acids include glycine, L-aspartic acid, L-cysteine, L-serine, L-alanine, L-methionine and the like.
EXAMPLES The present invention will be specifically described below with reference to examples and test examples, but the present invention is not limited to these examples.
[Example 1] Concentrated citrus molasses fermented products 1000 kg of Wenzhou mandarin oranges were squeezed with an in-line squeezer to obtain 500 kg of fruit juice and 500 kg of juice. Squeezed lime was added to about 500 kg of the squeezed residue (about 0.3%), and after rimming, squeezed to obtain 250 kg of juice and 250 kg of juice. This juice was circulated and concentrated to a Brix sugar content of 40 to 50% to obtain 50 kg of citrus molasses (Brix 45%, pH 8 to 9). Citrus molasses was stored frozen until use.
Thaw this citrus molasses, adjust pH with citric acid (pH 6.0 ± 0.5, 10 ± 5 ° C.), dilute with hot water (above 50 ° C.,
The depulped molasses was dissolved in warm water. Ammonium sulfate as a nutrient source (nitrogen source), Awabreak G-109 as an antifoaming agent, and citric acid as a pH adjuster were each dissolved in 5 times the amount of water and added to the above depulped molasses charging solution. The feed solution was adjusted to a Brix sugar content of 13 ± 1% and a pH of 5 ± 0.2. The amount of depulped molasses in the feed liquid was 27% (weight). The charged solution was cooled to 34 ± 4 ° C. after batch sterilization (85 ° C., 15 minutes). The charge was inoculated with baker's yeast (0.5%) and fermented. Yeast assimilate the sugar contained in the depulped citrus molasses to generate carbon dioxide, and as the fermentation proceeds, the Brix sugar content and pH decrease. The fermentation time is approximately 5-6 hours. The time point for completion of fermentation is determined when the Brix sugar content change after 30 minutes is 0.1% or less. After completion of the fermentation, the yeast was deactivated by heating (85 ° C., 15 minutes), and then sludge (yeast cells, pulp) contained in the fermentation broth was removed with a fully automatic press and a filter press. The supernatant was then sterilized (134 ° C., 3 seconds). Insoluble components produced during sterilization were removed with a Cuno filter and concentrated under reduced pressure. This concentrate was re-sterilized (8 ° C., 30 seconds) and then cooled to obtain 10 kg of the alcohol metabolism promoting composition (Brix 45 ± 2%) of the present invention.
[Example 2] Manufacture of Cordyceps extract 150 mL of M20Y2 medium was placed in a 500 mL Erlenmeyer flask and sterilized by autoclave. This medium was inoculated with 1 mL of cryopreserved mycelium of Cordyceps sinensis MF-20008 (FERM BP-5149) and cultured with shaking at 25 ° C. and 180 rpm for 5 days. Using this as an inoculum, large-scale culture of 150 L was performed as follows.
D medium (composition in 1 L: sucrose 40.0 g. K 2 HPO 4 4.0 g, asparagine 0.5 g, (NH 4 ) 2 HPO 4 2.0 g, MgSO 4 .7H 2 O 2.0 g,
[Example 3] Manufacture of a hangover prevention drink A hangover prevention drink was produced at the following raw material blending ratio (unit: kg).
Concentrated liquid of citrus molasses fermentation product (obtained in Production Example 1): 52.5
Cordyceps extract (obtained in Production Example 2): 16.7
Sugar: 40
Fruit juice: 100
Ascorbic acid: 1
Citric acid: 3
Fragrance: 4
Water: 782.8
Total amount 1000
After dissolving the above and sterilizing at 95 ° C. for 20 minutes, the bottle was aseptically filled in 120 mL units to obtain a hangover prevention drink.
[Test Example 1] Alcohol metabolism promoting action (in vivo)
Six-week-old male Wistar rats (body weight 160 to 170 g) were used. The concentrate of the citrus molasses fermentation product obtained in Example 1 and the Cordyceps extract obtained in Example 2 were used as test substances. As test groups, (1) concentrate 2,000 mg / kg administration group, (2) Cordyceps extract 200 mg / kg + concentrate 2,000 mg / kg administration group, and (3) distilled water administration group (10 mL) as a negative control group / Kg), 3 groups (6 per group) were set. After fasting for 24 hours, the concentrate solution dissolved in distilled water or distilled water was orally administered to 10 mL / kg body weight. One hour later, 20% (W / V) ethanol was orally administered so as to be 10 mL / kg body weight. One hour after ethanol administration, blood was collected from the femoral vein under ether anesthesia. Further, 3 hours after ethanol administration, blood was collected from the posterior vena cava under ether anesthesia. The blood ethanol concentration was measured using F kit ethanol (Roche Diagnostics). The results are shown in FIG. On the other hand, the blood acetaldehyde concentration was measured in accordance with the method of Cario Di Padova et al. (ALCHOLISM: CLINICAL AND EXPERIMENTAL RESERCH, vol. 10, No. 1, p86-89, 1986). That is, acetaldehyde was measured using HPLC (high performance liquid chromatography) after derivatization with a DNP (2,4 dinitrophenylhydrazine) reagent. The results are shown in FIG.
As is apparent from FIG. 1, blood alcohol concentrations after 1 hour and 3 hours after oral administration of ethanol are as follows: concentrate 2000 mg / kg administration group, Cordyceps extract 200 mg / kg + concentrate 2000 mg / kg administration group, negative control There was no statistically significant difference between the groups administered with distilled water (10 mL / kg).
On the other hand, as is clear from FIG. 2, the blood acetaldehyde concentration after oral administration of ethanol does not show a statistically significant difference between the concentrate administration group and the control group after 1 hour. It is observed that the blood acetaldehyde concentration is significantly decreased when the cordyceps extract is added thereto. After 3 hours, no difference was observed between the concentrate administration group and the control group, but the blood acetaldehyde concentration still decreased in the concentrate + Cordyceps extract administration group.
From the above results, by orally ingesting the citrus molasses fermentation product concentrate of the present invention before oral intake of alcohol, the ethanol concentration in the blood does not decrease, but the acetaldehyde concentration tends to decrease, together with the concentrate It was clarified that oral extract of Cordyceps sinensis extract enhanced the decrease in acetaldehyde concentration and prolonged the decrease time.
[Test Example 2] Effect of concentrated liquid of citrus molasses fermentation product on alcohol metabolizing enzyme activity What mechanism of action the hangover prevention effect obtained in the animal experiment described above is functioning in vitro A reaction system (Biochemical Experiment Course, Protein V, edited by Japanese Biochemical Society, p269-285) was constructed and examined.
The activity measurement of alcohol dehydrogenase and aldehyde dehydrogenase utilized the conversion of β-NAD, a coenzyme when these enzymes react, into NADH. β-NAD and NADH show a difference in absorption maximum wavelength in the ultraviolet region, and NADH absorption is observed in the vicinity of 340 nm, which is hardly seen in β-NAD. That is, measuring the ultraviolet absorption at 340 nm can be used as an index of the activity of the redox reaction of alcohol dehydrogenase and aldehyde dehydrogenase.
Alcohol dehydrogenase reaction solution sodium pyrophosphate (pH 10.0 prepared with phosphoric acid) 32 mM
Substrate: ethanol 33 mM
β-NAD 2.4 mM
Enzyme solution: alcohol dehydrogenase (SIGMA, EC 1.1.1.1, derived from horse liver, 5 mUnits / mL)
Purified water / aldehyde dehydrogenase reaction solution Sodium pyrophosphate (adjusted to pH 8.0 with phosphoric acid) 32 mM
Substrate:
β-
Pyrazole 0.1 mM
Enzyme solution: aldehyde dehydrogenase (SIGMA, EC 1.2.1.5, derived from baker's yeast, 0.5 Units / mL)
The purified water enzyme reaction solution was prepared so that the total amount was 0.2 mL. The substrate was added last, and the absorbance value at 340 nm was measured immediately after the addition of the substrate. Then, it was made to react at 37 degreeC for 10 minutes. The absorbance value at 340 nm after the reaction was measured, the amount of increase in the absorbance value was calculated, and the increase in enzyme activity was examined. The alcohol dehydrogenase activity is shown in FIG. 3, and the aldehyde dehydrogenase activity is shown in FIG. Even when the fermentation concentrate is added to the alcohol dehydrogenase reaction system at various concentrations, no change is observed in the enzyme activity as compared with the case where it is not added (FIG. 3). On the other hand, when the fermentation concentrate was added to the aldehyde dehydrogenase reaction system at various concentrations, the aldehyde dehydrogenase activity increased depending on the concentration of the fermentation concentrate. From this, it became clear that the fermentation concentrate has an effect of increasing the activity of the aldehyde dehydrogenase without affecting the alcohol dehydrogenase activity. From these experimental results, it became clear that the fermentation concentrate of citrus molasses promotes the decomposition of acetaldehyde by increasing the activity of aldehyde dehydrogenase and consequently attenuates the blood acetaldehyde concentration.
Industrial Applicability When the citrus molasses fermented concentrate of the present invention is orally ingested, the aldehyde dehydrogenase activity is enhanced, and when used together with Cordyceps extract, the enzyme activity is further enhanced and its duration Therefore, when these are taken orally before drinking, unpleasant symptoms such as hangover and sickness can be suppressed or reduced. Furthermore, since it does not affect the alcohol dehydrogenase activity, it is expected that the feeling of drunkenness (tipy feeling) will not be disturbed.
In addition, it is considered that the alcohol metabolism promoting composition of the present invention increases the ability of alcohol metabolism by continuously ingesting, and is useful for preventing alcohol dependence and organ damage such as liver.
[Brief description of the drawings]
FIG. 1 shows that 2,000 mg / kg oral concentrate of fermented citrus molasses and 200 mg / kg of Cordyceps extract + 2000 mg / kg oral concentrate of rats were converted to the blood alcohol concentration by the subsequent oral administration of ethanol. It is a graph which shows the influence which exerts.
FIG. 2 is also a graph showing the effect on blood acetaldehyde concentration. *: P <0.05 (Student's test)
FIG. 3: is a figure which shows the effect which acts on the alcohol dehydrogenase activity of the concentrate of the fermentation product of citrus molasses in vitro.
FIG. 4 is also a graph showing the effect on aldehyde dehydrogenase activity.
Claims (15)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002505020A JP4852218B2 (en) | 2000-06-20 | 2001-06-20 | Alcohol metabolism promoter composition |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000184354 | 2000-06-20 | ||
| JP2000184354 | 2000-06-20 | ||
| JP2000-184354 | 2000-06-20 | ||
| PCT/JP2001/005259 WO2002000238A1 (en) | 2000-06-20 | 2001-06-20 | Compositions promoting alcohol metabolism |
| JP2002505020A JP4852218B2 (en) | 2000-06-20 | 2001-06-20 | Alcohol metabolism promoter composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011208931A Division JP2012017337A (en) | 2000-06-20 | 2011-09-26 | Composition for alcohol metabolism promotion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2002000238A1 JPWO2002000238A1 (en) | 2003-09-24 |
| JP4852218B2 true JP4852218B2 (en) | 2012-01-11 |
Family
ID=18684809
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002505020A Expired - Fee Related JP4852218B2 (en) | 2000-06-20 | 2001-06-20 | Alcohol metabolism promoter composition |
| JP2011208931A Pending JP2012017337A (en) | 2000-06-20 | 2011-09-26 | Composition for alcohol metabolism promotion |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011208931A Pending JP2012017337A (en) | 2000-06-20 | 2011-09-26 | Composition for alcohol metabolism promotion |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JP4852218B2 (en) |
| AU (1) | AU2001274564A1 (en) |
| WO (1) | WO2002000238A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100927215B1 (en) * | 2008-05-29 | 2009-11-16 | 장영삼 | Alcoholic additives and preparation method thereof |
| JP2009108099A (en) * | 2009-01-13 | 2009-05-21 | Meiji Milk Prod Co Ltd | Composition for prevention or improvement of cerebrovascular disorder |
| JP2013526324A (en) | 2010-05-13 | 2013-06-24 | エアクラフト メディカル リミテッド | Laryngoscope insertion section structure |
| JP5740926B2 (en) * | 2010-11-16 | 2015-07-01 | 不二製油株式会社 | Paste product and its manufacturing method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5959185A (en) * | 1982-09-28 | 1984-04-04 | Kawachichiyou | Preparation of fruit spirit |
| JPS61108366A (en) * | 1984-11-01 | 1986-05-27 | Yasuji Yoshida | Preparation of citrus liquor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60126066A (en) * | 1983-12-07 | 1985-07-05 | Tadasu Sawabe | Recovery of fruit juice remaining in squeezed lees of citrus fruit and device for recovering it |
| JP2678770B2 (en) * | 1988-08-30 | 1997-11-17 | 株式会社中埜酢店 | New food material manufacturing method |
| JP3262999B2 (en) * | 1997-04-03 | 2002-03-04 | 愛媛県農業協同組合連合会 | Effective use of citrus juice residue |
-
2001
- 2001-06-20 WO PCT/JP2001/005259 patent/WO2002000238A1/en not_active Ceased
- 2001-06-20 JP JP2002505020A patent/JP4852218B2/en not_active Expired - Fee Related
- 2001-06-20 AU AU2001274564A patent/AU2001274564A1/en not_active Abandoned
-
2011
- 2011-09-26 JP JP2011208931A patent/JP2012017337A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5959185A (en) * | 1982-09-28 | 1984-04-04 | Kawachichiyou | Preparation of fruit spirit |
| JPS61108366A (en) * | 1984-11-01 | 1986-05-27 | Yasuji Yoshida | Preparation of citrus liquor |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012017337A (en) | 2012-01-26 |
| AU2001274564A1 (en) | 2002-01-08 |
| WO2002000238A1 (en) | 2002-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2209237C2 (en) | Method for production of beer with enhanced biological value | |
| CN103907987B (en) | A kind of multi-cultur es mixing is continuously fermented and is prepared the method for Haw Apple Vinegar Drink | |
| US4797290A (en) | Lyophilized process for the production of a kefir yoghurt | |
| KR101301094B1 (en) | Composition for relieving hangover or improving liver function | |
| CN105482953A (en) | Production process of selenium-rich blueberry healthcare wine | |
| CN101624560A (en) | Preparation method of kelp fruit wine | |
| WO2008156297A2 (en) | Composition for preventing or treating katzenjammer | |
| CN106190691A (en) | A kind of production method of Caulis Sacchari sinensis Fragrant fruit wine | |
| CN106085799A (en) | A kind of multi-cultur es co-immobilization fermentation Fructus Mori fruit vinegar and preparation method thereof | |
| CN106085713A (en) | A kind of two microorganisms co-immobilization fermentation mulberry wine and preparation method thereof | |
| JP2012017337A (en) | Composition for alcohol metabolism promotion | |
| US20210321643A1 (en) | Method for preparation of nitrite ion-containing allium tuberosum fermentate and composition thereof | |
| CN104382129A (en) | Beverage prepared from sweet corn and black tea fungus | |
| CN106387917A (en) | Preparation method of antialcoholism product | |
| US20210153537A1 (en) | Compound beverage containing corn peptides and pueraria root extract and preparation method thereof | |
| JP2010100663A (en) | Enzyme inhibitor containing fermentation product of allium cepa l | |
| JP2005097222A (en) | Fermented onion | |
| CN106889389A (en) | A kind of wild white bur oral liquid and preparation method thereof | |
| JPWO2002000238A1 (en) | Alcohol metabolism promoter composition | |
| CN111518656A (en) | Fruit wine and preparation method thereof | |
| JP4885611B2 (en) | Gamma-aminobutyric acid-containing ginseng fermented product and method for producing the same | |
| JP2024500742A (en) | Microorganisms with high tripeptide production ability and their uses | |
| KR102151373B1 (en) | Food Composition for Preventing and Improving Allergy Comprising Fermented Noni and Method for Preparing the Same | |
| JP2001192342A (en) | Method for producing stevia concentrate and mature pomegranate mixture | |
| KR102532514B1 (en) | A composition for ameliorating hangover comprising Fagopyrum tataricum extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080618 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110809 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110926 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111018 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111024 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4852218 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141028 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |